Free Delivery Over $100
|
|
|||
|
||||
OverviewEdited by experts from one of the world’s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) Ras inhibitors Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) Lenalidomide analogs New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) Thrombopoietic agents Leukemias: Principles and Practice of Therapy Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area Full Product DetailsAuthor: Stefan Faderl (Associate Professor, Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA) , Hagop Kantarjian (Chairman & Professor, Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA)Publisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Dimensions: Width: 22.50cm , Height: 2.60cm , Length: 28.50cm Weight: 1.497kg ISBN: 9781405182355ISBN 10: 1405182350 Pages: 456 Publication Date: 23 November 2010 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock  The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsThis high quality book will be an excellent reference for both fellows and attending physicians who care for patients with leukemic disorders in either a community or academic setting ... This book is a welcome resource for those entering the field as well as for long-time practitioners who want to stay up to date. (Doody's, 12 August 2011) This high quality book will be an excellent reference for both fellows and attending physicians who care for patients with leukemic disorders in either a community or academic setting . . . This book is a welcome resource for those entering the field as well as for long-time practitioners who want to stay up to date. (Doody's, 12 August 2011) Author InformationDr. Stefan Faderl specializes in acute and chronic leukemias. His main areas of interest include acute lymphoblastic leukemias (ALL), acute myeloid leukemias (AML), chronic lymphocytic leukemia (CLL) and its variants, as well as chronic myeloid leukemias (CML). Dr. Hagop M. Kantarjian is Professor of Medicine and Chairman of the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas. He specializes in leukemia and is interested in creating new treatment approaches for these diseases. He has authored and contributed to over 560 medical publications, articles, and abstracts. Tab Content 6Author Website:Countries AvailableAll regions |
||||
